Antibiotic Therapy Versus Appendectomy for Acute Appendicitis
Information source: Assistance Publique - Hôpitaux de Paris
Information obtained from ClinicalTrials.gov on November 03, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Appendicitis
Intervention: amoxicillin/clavulanate potassium (Drug); appendectomy (Procedure); computed tomography (CT) scanning (Procedure)
Phase: N/A
Status: Recruiting
Sponsored by: Assistance Publique - Hôpitaux de Paris Official(s) and/or principal investigator(s): Corinne Vons, MD,PhD, Principal Investigator, Affiliation: AP-HP
Overall contact: Corinne Vons, MD,PhD, Phone: 33145374545, Email: corinne.vons@abc.ap-hop-paris.fr
Summary
The purpose of the study is to demonstrate that antibiotic therapy is as safe and effective
as appendectomy for the treatment of acute non complicated appendicitis. Two hundred fifty
patients will be included in a prospective multicentric randomized trial. The primary
endpoint is the rate of intra abdominal infections following both therapeutic strategies.
Other criteria will be studied including duration of hospital stay and absence from work
during a follow up period of one year, parietal and abdominal complications and recurrent
appendicitis after antibiotic therapy.
Clinical Details
Official title: A Prospective Randomized Multicentric Trial Comparing Amoxicillin/Clavulanate Potassium Therapy to Appendectomy for Acute Non Complicated Appendicitis
Study design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety Study
Primary outcome: rate of intra abdominal infections following both therapeutic strategies
Secondary outcome: duration of painduration of hospitalisation duration of absence from work rate of wound infection recurrence of appendicitis rate of abdominal hernia rate of adhesive intestinal occlusion cost
Detailed description:
Appendectomy is the most frequent intra-abdominal operation performed, accounting for the
majority of admissions in a general surgery unit. Appendectomy has always been considered the
cornerstone in the treatment of acute appendicitis. Nevertheless, the idea of a conservative
treatment using antibiotics is not that recent. Current practices have proven the efficiency
of antibiotic therapy in treating certain infectious abdominal conditions including:
appendicular mass with or without periappendicular abscess and acute diverticulitis. This
success has prompted the researchers to consider the exclusive use of antibiotic therapy in
the treatment of non complicated appendicitis.
In patients with clinical suspicion of acute appendicitis (localized abdominal tenderness,
inflammatory reaction...etc) a CT scan will be performed to confirm the diagnosis of non
complicated appendicitis. This diagnosis is confirmed on the CT in the absence of any sign of
either localized peritonitis, and/or perforation (extraluminal gas, appendicular abscess, or
phlegmon).
After a thorough explanation of this study, the patient will be obliged to sign a written
consent. Patients will be randomly assigned to either one of the two therapeutic modalities
: an appendectomy,or an antibiotic treatment consisting of amoxicillin and clavulanate
potassium.
This therapy will be continued until the normalisation of leucocytic count and C reactive
protein are achieved. In order to demonstrate equivalent conclusive results comparing the two
treatment modalities, the statistical consultant estimated the inclusion of at least 200
patients in the study. However, after considering the possible loss of a number of patients
following their inclusion for a variety of reasons, it was decided that a total of 250
patients will be enrolled.
Rate of intra abdominal infections following both therapeutic strategies is the first
endpoint to be compared. Duration of pain, diet, hospitalisation, absence from work will also
be compared. In the group of patients treated by antibiotics, the rate of recurrent
appendicitis after treatment will be evaluated, but is not considered a complication as long
as the recurrence of the appendicitis is uncomplicated. During the followup period of one
year, long-term complications will be observed including: abdominal hernia, adhesive
intestinal occlusion, and others.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Before CT scanning
Inclusion Criteria:
- Clinical suspicion of appendicitis
- Age more than 18 years
Exclusion Criteria:
- Clinical signs of generalized peritonitis
- Previous take of antibiotics within the 5 days preceding the presentation
- Allergy or intolerance to lactamases and/or clavulanate potassium
- Corticosteroid or anticoagulant therapy
- Patient with a known inflammatory bowel disease (Crohn's disease or ulcerative
colitis)
- Pregnant women
- Patient with iode allergy
- Renal insufficiency (creatinine > 200 )
CT scanning:
Inclusion Criteria:
- Appendix diameter > 6 mm
Exclusion Criteria:
- Appendix non visualised
- Signs of localized peritonitis:
- extradigestive gas
- fluid collection around the appendix
- generalized intraperitoneal fluid
Locations and Contacts
Corinne Vons, MD,PhD, Phone: 33145374545, Email: corinne.vons@abc.ap-hop-paris.fr
Antoine Béclère Hospital - Department of Surgery, Clamart 92141 cedex, France; Recruiting Corinne Vons, MD, PhD, Phone: 33145374545, Email: corinne.vons@abc.ap-hop-paris.fr Corinne Vons, Md PhD, Principal Investigator Claude Smadja, MD PhD, Sub-Investigator Yan Proske, MD, Sub-Investigator Alessio Carloni, MD, Sub-Investigator Ibrahim Dagher, MD PhD, Sub-Investigator Delphine Poussin, MD, Sub-Investigator Ruben Balzarotti, MD, Sub-Investigator
Lariboisière Hospital, Department of Digestive Surgery, Paris 75475, France; Recruiting Philippe Taleb, MD, Phone: 33149956565, Email: philippe.taleb@lrb.ap-hop-paris.fr Arnaud Alves, MD, Principal Investigator Philippe Taleb, MD, Principal Investigator Patrice Valleur, MD, Sub-Investigator Yves Panis, MD PhD, Sub-Investigator
Cochin Hospital, Department of Digestive Surgery, Paris 75014, France; Recruiting Thillois Jean Marc, MD, Phone: 33158414141, Email: jean-marc.thillois@cch.ap-hop-paris.fr Jean-Marc Thillois, MD, Principal Investigator Olivier Soubrane, MD PhD, Sub-Investigator Bertrand Dousset, MD PhD, Sub-Investigator Philippe Bonnichon, MD, Sub-Investigator Pierre Philippe Massault, MD, Sub-Investigator Sylvie Gueroult, MD, Principal Investigator Rémi Cerceau, MD, Sub-Investigator Bruno Randone, MD, Sub-Investigator
Hotel Dieu Hospital, Department of Digestive Surgery, Paris 75004, France; Recruiting Stéphane Servajean, MD, Phone: 33142348234, Email: stephane.servajean@htd.ap-hop-paris.fr Stéphane Servajean, MD, Principal Investigator Jean-Luc Bouillot, MD, Sub-Investigator
Bicêtre Hospital, Department of Digestive Surgery, "Kremlin Bicêtre" 94275, France; Suspended
Henri Mondor Hospital, Creteil 94, France; Active, not recruiting
Additional Information
Starting date: February 2004
Ending date: February 2007
Last updated: February 1, 2006
|